nodes	percent_of_prediction	percent_of_DWPC	metapath
Adefovir Dipivoxil—NME2—ovarian cancer	0.63	1	CbGaD
Adefovir Dipivoxil—SLC22A3—Melphalan—ovarian cancer	0.196	1	CbGbCtD
Adefovir Dipivoxil—Tenofovir—NME2—ovarian cancer	0.00442	1	CrCbGaD
Adefovir Dipivoxil—AK4—Irinotecan—Topotecan—ovarian cancer	0.00352	1	CbGdCrCtD
Adefovir Dipivoxil—AK2—myometrium—ovarian cancer	0.00267	0.0499	CbGeAlD
Adefovir Dipivoxil—NME1-NME2—female reproductive system—ovarian cancer	0.00206	0.0384	CbGeAlD
Adefovir Dipivoxil—AK4—myometrium—ovarian cancer	0.00198	0.0369	CbGeAlD
Adefovir Dipivoxil—NME2—embryo—ovarian cancer	0.00186	0.0347	CbGeAlD
Adefovir Dipivoxil—AK2—uterus—ovarian cancer	0.00173	0.0324	CbGeAlD
Adefovir Dipivoxil—AK4—uterine cervix—ovarian cancer	0.00154	0.0287	CbGeAlD
Adefovir Dipivoxil—NME2—epithelium—ovarian cancer	0.00152	0.0283	CbGeAlD
Adefovir Dipivoxil—AK2—bone marrow—ovarian cancer	0.00147	0.0275	CbGeAlD
Adefovir Dipivoxil—AK4—decidua—ovarian cancer	0.00147	0.0274	CbGeAlD
Adefovir Dipivoxil—AK2—female gonad—ovarian cancer	0.00142	0.0265	CbGeAlD
Adefovir Dipivoxil—AK2—vagina—ovarian cancer	0.00141	0.0263	CbGeAlD
Adefovir Dipivoxil—AK4—endometrium—ovarian cancer	0.00139	0.026	CbGeAlD
Adefovir Dipivoxil—NME1—uterus—ovarian cancer	0.00133	0.0248	CbGeAlD
Adefovir Dipivoxil—AK4—gonad—ovarian cancer	0.00129	0.0241	CbGeAlD
Adefovir Dipivoxil—AK4—uterus—ovarian cancer	0.00128	0.0239	CbGeAlD
Adefovir Dipivoxil—AK2—testis—ovarian cancer	0.00126	0.0235	CbGeAlD
Adefovir Dipivoxil—NME1-NME2—lymph node—ovarian cancer	0.0012	0.0225	CbGeAlD
Adefovir Dipivoxil—NME1—female reproductive system—ovarian cancer	0.0012	0.0223	CbGeAlD
Adefovir Dipivoxil—AK4—female reproductive system—ovarian cancer	0.00115	0.0215	CbGeAlD
Adefovir Dipivoxil—NME1—bone marrow—ovarian cancer	0.00113	0.0211	CbGeAlD
Adefovir Dipivoxil—NME2—female reproductive system—ovarian cancer	0.00113	0.021	CbGeAlD
Adefovir Dipivoxil—NME1—female gonad—ovarian cancer	0.00109	0.0203	CbGeAlD
Adefovir Dipivoxil—AK4—female gonad—ovarian cancer	0.00105	0.0196	CbGeAlD
Adefovir Dipivoxil—AK4—vagina—ovarian cancer	0.00104	0.0195	CbGeAlD
Adefovir Dipivoxil—NME2—female gonad—ovarian cancer	0.00102	0.0191	CbGeAlD
Adefovir Dipivoxil—NME1—testis—ovarian cancer	0.000965	0.018	CbGeAlD
Adefovir Dipivoxil—AK4—testis—ovarian cancer	0.00093	0.0174	CbGeAlD
Adefovir Dipivoxil—AK2—lymph node—ovarian cancer	0.000911	0.017	CbGeAlD
Adefovir Dipivoxil—NME2—testis—ovarian cancer	0.000909	0.017	CbGeAlD
Adefovir Dipivoxil—ABCC5—uterine cervix—ovarian cancer	0.000873	0.0163	CbGeAlD
Adefovir Dipivoxil—ABCC5—decidua—ovarian cancer	0.000832	0.0155	CbGeAlD
Adefovir Dipivoxil—SLC22A3—myometrium—ovarian cancer	0.000802	0.015	CbGeAlD
Adefovir Dipivoxil—SLC22A3—embryo—ovarian cancer	0.000772	0.0144	CbGeAlD
Adefovir Dipivoxil—NME1—lymph node—ovarian cancer	0.000699	0.0131	CbGeAlD
Adefovir Dipivoxil—AK4—lymph node—ovarian cancer	0.000674	0.0126	CbGeAlD
Adefovir Dipivoxil—NME2—lymph node—ovarian cancer	0.000659	0.0123	CbGeAlD
Adefovir Dipivoxil—SLC22A3—uterine cervix—ovarian cancer	0.000624	0.0117	CbGeAlD
Adefovir Dipivoxil—ABCC5—bone marrow—ovarian cancer	0.000618	0.0115	CbGeAlD
Adefovir Dipivoxil—ABCC5—female gonad—ovarian cancer	0.000595	0.0111	CbGeAlD
Adefovir Dipivoxil—ABCC5—vagina—ovarian cancer	0.000592	0.0111	CbGeAlD
Adefovir Dipivoxil—SLC22A3—endometrium—ovarian cancer	0.000565	0.0105	CbGeAlD
Adefovir Dipivoxil—ABCC5—testis—ovarian cancer	0.000528	0.00986	CbGeAlD
Adefovir Dipivoxil—SLC22A3—gonad—ovarian cancer	0.000524	0.00978	CbGeAlD
Adefovir Dipivoxil—ABCC4—uterus—ovarian cancer	0.000504	0.00942	CbGeAlD
Adefovir Dipivoxil—SLC22A3—female reproductive system—ovarian cancer	0.000468	0.00874	CbGeAlD
Adefovir Dipivoxil—ABCC4—female reproductive system—ovarian cancer	0.000453	0.00847	CbGeAlD
Adefovir Dipivoxil—ABCC4—bone marrow—ovarian cancer	0.000428	0.008	CbGeAlD
Adefovir Dipivoxil—SLC22A3—female gonad—ovarian cancer	0.000426	0.00795	CbGeAlD
Adefovir Dipivoxil—SLC22A3—vagina—ovarian cancer	0.000423	0.0079	CbGeAlD
Adefovir Dipivoxil—ABCC4—female gonad—ovarian cancer	0.000413	0.00771	CbGeAlD
Adefovir Dipivoxil—ABCC5—lymph node—ovarian cancer	0.000383	0.00715	CbGeAlD
Adefovir Dipivoxil—SLC22A3—testis—ovarian cancer	0.000377	0.00705	CbGeAlD
Adefovir Dipivoxil—ABCC4—testis—ovarian cancer	0.000366	0.00684	CbGeAlD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—TERT—ovarian cancer	0.000294	0.00595	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—lymph node—ovarian cancer	0.000274	0.00511	CbGeAlD
Adefovir Dipivoxil—ABCC4—lymph node—ovarian cancer	0.000265	0.00496	CbGeAlD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—CASP3—ovarian cancer	0.00026	0.00526	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—NME2—ovarian cancer	0.00026	0.00526	CbGpPWpGaD
Adefovir Dipivoxil—Chest pain—Topotecan—ovarian cancer	0.000259	0.00409	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Topotecan—ovarian cancer	0.000259	0.00409	CcSEcCtD
Adefovir Dipivoxil—Renal impairment—Docetaxel—ovarian cancer	0.000259	0.00409	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.000257	0.00406	CcSEcCtD
Adefovir Dipivoxil—Alanine aminotransferase increased—Paclitaxel—ovarian cancer	0.000256	0.00405	CcSEcCtD
Adefovir Dipivoxil—NME1—Arf6 trafficking events—CTNNB1—ovarian cancer	0.000255	0.00516	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Fluoropyrimidine Activity—TYMS—ovarian cancer	0.000254	0.00514	CbGpPWpGaD
Adefovir Dipivoxil—Myalgia—Melphalan—ovarian cancer	0.000253	0.004	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Melphalan—ovarian cancer	0.000253	0.004	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.000252	0.00397	CcSEcCtD
Adefovir Dipivoxil—Back pain—Vinorelbine—ovarian cancer	0.000251	0.00397	CcSEcCtD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—CTNNB1—ovarian cancer	0.000251	0.00507	CbGpPWpGaD
Adefovir Dipivoxil—Cough increased—Epirubicin—ovarian cancer	0.00025	0.00395	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Paclitaxel—ovarian cancer	0.000246	0.00389	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Chlorambucil—ovarian cancer	0.000245	0.00387	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Topotecan—ovarian cancer	0.000243	0.00384	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Topotecan—ovarian cancer	0.000243	0.00384	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Chlorambucil—ovarian cancer	0.000242	0.00383	CcSEcCtD
Adefovir Dipivoxil—ABCC4—ABC-family proteins mediated transport—ABCB1—ovarian cancer	0.000241	0.00488	CbGpPWpGaD
Adefovir Dipivoxil—Skin disorder—Topotecan—ovarian cancer	0.000241	0.00381	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.00024	0.0038	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Vinorelbine—ovarian cancer	0.00024	0.0038	CcSEcCtD
Adefovir Dipivoxil—Creatinine increased—Epirubicin—ovarian cancer	0.00024	0.0038	CcSEcCtD
Adefovir Dipivoxil—Bone pain—Epirubicin—ovarian cancer	0.000239	0.00377	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Melphalan—ovarian cancer	0.000238	0.00376	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Topotecan—ovarian cancer	0.000236	0.00374	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Melphalan—ovarian cancer	0.000236	0.00373	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Melphalan—ovarian cancer	0.000231	0.00366	CcSEcCtD
Adefovir Dipivoxil—Cough increased—Doxorubicin—ovarian cancer	0.000231	0.00365	CcSEcCtD
Adefovir Dipivoxil—Hepatocellular injury—Epirubicin—ovarian cancer	0.000229	0.00361	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.000228	0.0036	CcSEcCtD
Adefovir Dipivoxil—Liver function test abnormal—Docetaxel—ovarian cancer	0.000227	0.00359	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Paclitaxel—ovarian cancer	0.000227	0.00359	CcSEcCtD
Adefovir Dipivoxil—Cough—Vinorelbine—ovarian cancer	0.000227	0.00358	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	0.000226	0.00458	CbGpPWpGaD
Adefovir Dipivoxil—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.000226	0.00357	CcSEcCtD
Adefovir Dipivoxil—Hyperkalaemia—Epirubicin—ovarian cancer	0.000225	0.00355	CcSEcCtD
Adefovir Dipivoxil—Creatinine increased—Doxorubicin—ovarian cancer	0.000222	0.00351	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Vinorelbine—ovarian cancer	0.000221	0.0035	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Vinorelbine—ovarian cancer	0.000221	0.0035	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.000221	0.0035	CcSEcCtD
Adefovir Dipivoxil—Bone pain—Doxorubicin—ovarian cancer	0.000221	0.00349	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Chlorambucil—ovarian cancer	0.00022	0.00348	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Chlorambucil—ovarian cancer	0.00022	0.00348	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Paclitaxel—ovarian cancer	0.00022	0.00348	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.00022	0.00347	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Topotecan—ovarian cancer	0.000218	0.00345	CcSEcCtD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—MMP9—ovarian cancer	0.000218	0.00441	CbGpPWpGaD
Adefovir Dipivoxil—NME1—E-cadherin signaling in the nascent adherens junction—PIK3CA—ovarian cancer	0.000217	0.00439	CbGpPWpGaD
Adefovir Dipivoxil—Alanine aminotransferase increased—Docetaxel—ovarian cancer	0.000217	0.00343	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Topotecan—ovarian cancer	0.000216	0.00341	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Topotecan—ovarian cancer	0.000214	0.00338	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Melphalan—ovarian cancer	0.000214	0.00338	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Paclitaxel—ovarian cancer	0.000213	0.00337	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Paclitaxel—ovarian cancer	0.000212	0.00334	CcSEcCtD
Adefovir Dipivoxil—Hepatocellular injury—Doxorubicin—ovarian cancer	0.000212	0.00334	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Melphalan—ovarian cancer	0.000211	0.00334	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Paclitaxel—ovarian cancer	0.00021	0.00332	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00021	0.00331	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Vinorelbine—ovarian cancer	0.000208	0.00329	CcSEcCtD
Adefovir Dipivoxil—Hyperkalaemia—Doxorubicin—ovarian cancer	0.000208	0.00328	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Vinorelbine—ovarian cancer	0.000208	0.00328	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	0.000207	0.00418	CbGpPWpGaD
Adefovir Dipivoxil—Skin disorder—Vinorelbine—ovarian cancer	0.000206	0.00326	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Topotecan—ovarian cancer	0.000203	0.0032	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Vinorelbine—ovarian cancer	0.000202	0.0032	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Chlorambucil—ovarian cancer	0.0002	0.00316	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Paclitaxel—ovarian cancer	0.000199	0.00315	CcSEcCtD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—ovarian cancer	0.000199	0.00402	CbGpPWpGaD
Adefovir Dipivoxil—Urinary tract disorder—Paclitaxel—ovarian cancer	0.000198	0.00313	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Paclitaxel—ovarian cancer	0.000197	0.00312	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Chlorambucil—ovarian cancer	0.000197	0.00311	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Paclitaxel—ovarian cancer	0.000197	0.00311	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Topotecan—ovarian cancer	0.000196	0.0031	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Topotecan—ovarian cancer	0.000196	0.0031	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	0.000194	0.00392	CbGpPWpGaD
Adefovir Dipivoxil—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000193	0.00305	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Docetaxel—ovarian cancer	0.000192	0.00304	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Chlorambucil—ovarian cancer	0.000191	0.00301	CcSEcCtD
Adefovir Dipivoxil—Hepatic function abnormal—Epirubicin—ovarian cancer	0.00019	0.003	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—SPARC—ovarian cancer	0.00019	0.00384	CbGpPWpGaD
Adefovir Dipivoxil—Renal failure—Docetaxel—ovarian cancer	0.000186	0.00295	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Docetaxel—ovarian cancer	0.000185	0.00292	CcSEcCtD
Adefovir Dipivoxil—Hepatic failure—Epirubicin—ovarian cancer	0.000185	0.00292	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Vinorelbine—ovarian cancer	0.000184	0.00291	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000183	0.00289	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—SPARC—ovarian cancer	0.000181	0.00366	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—MYC—ovarian cancer	0.00018	0.00364	CbGpPWpGaD
Adefovir Dipivoxil—Hepatobiliary disease—Docetaxel—ovarian cancer	0.000179	0.00283	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Topotecan—ovarian cancer	0.000178	0.00281	CcSEcCtD
Adefovir Dipivoxil—NME1—E-cadherin signaling in the nascent adherens junction—AKT1—ovarian cancer	0.000177	0.00359	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Chlorambucil—ovarian cancer	0.000177	0.0028	CcSEcCtD
Adefovir Dipivoxil—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.000176	0.00278	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Topotecan—ovarian cancer	0.000175	0.00277	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	0.000175	0.00354	CbGpPWpGaD
Adefovir Dipivoxil—Malnutrition—Paclitaxel—ovarian cancer	0.000175	0.00276	CcSEcCtD
Adefovir Dipivoxil—Renal impairment—Epirubicin—ovarian cancer	0.000174	0.00276	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Melphalan—ovarian cancer	0.000174	0.00275	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000173	0.00274	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Paclitaxel—ovarian cancer	0.000172	0.00272	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Melphalan—ovarian cancer	0.000172	0.00271	CcSEcCtD
Adefovir Dipivoxil—Hepatic failure—Doxorubicin—ovarian cancer	0.000171	0.0027	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Docetaxel—ovarian cancer	0.00017	0.00269	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Topotecan—ovarian cancer	0.00017	0.00268	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	0.00017	0.00343	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	0.00017	0.00343	CbGpPWpGaD
Adefovir Dipivoxil—Back pain—Paclitaxel—ovarian cancer	0.000169	0.00267	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Docetaxel—ovarian cancer	0.000169	0.00267	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Docetaxel—ovarian cancer	0.000168	0.00266	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Vinorelbine—ovarian cancer	0.000168	0.00265	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Vinorelbine—ovarian cancer	0.000168	0.00265	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—CYTB—ovarian cancer	0.000168	0.00339	CbGpPWpGaD
Adefovir Dipivoxil—Connective tissue disorder—Docetaxel—ovarian cancer	0.000167	0.00264	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Docetaxel—ovarian cancer	0.000167	0.00264	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	0.000167	0.00337	CbGpPWpGaD
Adefovir Dipivoxil—Diarrhoea—Melphalan—ovarian cancer	0.000166	0.00263	CcSEcCtD
Adefovir Dipivoxil—Nausea—Chlorambucil—ovarian cancer	0.000165	0.00261	CcSEcCtD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—MMP9—ovarian cancer	0.000165	0.00334	CbGpPWpGaD
Adefovir Dipivoxil—Anaemia—Paclitaxel—ovarian cancer	0.000162	0.00255	CcSEcCtD
Adefovir Dipivoxil—Renal impairment—Doxorubicin—ovarian cancer	0.000161	0.00255	CcSEcCtD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—ovarian cancer	0.00016	0.00323	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Topotecan—ovarian cancer	0.000158	0.00249	CcSEcCtD
Adefovir Dipivoxil—Rash—Topotecan—ovarian cancer	0.000156	0.00247	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Topotecan—ovarian cancer	0.000156	0.00247	CcSEcCtD
Adefovir Dipivoxil—Blood creatinine increased—Epirubicin—ovarian cancer	0.000155	0.00246	CcSEcCtD
Adefovir Dipivoxil—Headache—Topotecan—ovarian cancer	0.000155	0.00245	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Melphalan—ovarian cancer	0.000154	0.00244	CcSEcCtD
Adefovir Dipivoxil—Liver function test abnormal—Epirubicin—ovarian cancer	0.000153	0.00242	CcSEcCtD
Adefovir Dipivoxil—Rash—Melphalan—ovarian cancer	0.000153	0.00242	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Melphalan—ovarian cancer	0.000153	0.00242	CcSEcCtD
Adefovir Dipivoxil—Cough—Paclitaxel—ovarian cancer	0.000153	0.00241	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Vinorelbine—ovarian cancer	0.000152	0.00241	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Ectoderm Differentiation—HDAC6—ovarian cancer	0.000152	0.00308	CbGpPWpGaD
Adefovir Dipivoxil—Pruritus—Vinorelbine—ovarian cancer	0.00015	0.00237	CcSEcCtD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—SLC5A5—ovarian cancer	0.000149	0.00301	CbGpPWpGaD
Adefovir Dipivoxil—Chest pain—Paclitaxel—ovarian cancer	0.000149	0.00235	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Paclitaxel—ovarian cancer	0.000149	0.00235	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Docetaxel—ovarian cancer	0.000148	0.00234	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000148	0.00234	CcSEcCtD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—TP53—ovarian cancer	0.000148	0.00299	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Topotecan—ovarian cancer	0.000147	0.00233	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—PPP1CC—ovarian cancer	0.000146	0.00296	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—BRIP1—ovarian cancer	0.000146	0.00296	CbGpPWpGaD
Adefovir Dipivoxil—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.000146	0.00231	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Vinorelbine—ovarian cancer	0.000145	0.00229	CcSEcCtD
Adefovir Dipivoxil—Nausea—Melphalan—ovarian cancer	0.000144	0.00228	CcSEcCtD
Adefovir Dipivoxil—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000144	0.00227	CcSEcCtD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—SLC2A1—ovarian cancer	0.000144	0.00291	CbGpPWpGaD
Adefovir Dipivoxil—Back pain—Docetaxel—ovarian cancer	0.000143	0.00227	CcSEcCtD
Adefovir Dipivoxil—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000142	0.00224	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Epirubicin—ovarian cancer	0.000141	0.00222	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Paclitaxel—ovarian cancer	0.00014	0.00221	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00014	0.00221	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Paclitaxel—ovarian cancer	0.000139	0.00219	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—SOD1—ovarian cancer	0.000138	0.00279	CbGpPWpGaD
Adefovir Dipivoxil—Anaemia—Docetaxel—ovarian cancer	0.000137	0.00216	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—NME2—ovarian cancer	0.000137	0.00276	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—MYC—ovarian cancer	0.000136	0.00276	CbGpPWpGaD
Adefovir Dipivoxil—Anorexia—Paclitaxel—ovarian cancer	0.000136	0.00215	CcSEcCtD
Adefovir Dipivoxil—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000135	0.00214	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Vinorelbine—ovarian cancer	0.000135	0.00213	CcSEcCtD
Adefovir Dipivoxil—Rash—Vinorelbine—ovarian cancer	0.000134	0.00211	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Vinorelbine—ovarian cancer	0.000134	0.00211	CcSEcCtD
Adefovir Dipivoxil—Headache—Vinorelbine—ovarian cancer	0.000133	0.0021	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—SOD1—ovarian cancer	0.000131	0.00266	CbGpPWpGaD
Adefovir Dipivoxil—Pancreatitis—Doxorubicin—ovarian cancer	0.00013	0.00206	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00013	0.00205	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Epirubicin—ovarian cancer	0.00013	0.00205	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	0.000129	0.00262	CbGpPWpGaD
Adefovir Dipivoxil—Cough—Docetaxel—ovarian cancer	0.000129	0.00204	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Docetaxel—ovarian cancer	0.000126	0.00199	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Docetaxel—ovarian cancer	0.000126	0.00199	CcSEcCtD
Adefovir Dipivoxil—Nausea—Vinorelbine—ovarian cancer	0.000126	0.00199	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Epirubicin—ovarian cancer	0.000126	0.00199	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Paclitaxel—ovarian cancer	0.000126	0.00198	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000125	0.00198	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Epirubicin—ovarian cancer	0.000125	0.00197	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Paclitaxel—ovarian cancer	0.000124	0.00196	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000123	0.00195	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	0.000122	0.00247	CbGpPWpGaD
Adefovir Dipivoxil—Haematuria—Epirubicin—ovarian cancer	0.000122	0.00193	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Fluoropyrimidine Activity—TP53—ovarian cancer	0.000122	0.00246	CbGpPWpGaD
Adefovir Dipivoxil—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000121	0.00191	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Doxorubicin—ovarian cancer	0.00012	0.0019	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Epirubicin—ovarian cancer	0.00012	0.0019	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Docetaxel—ovarian cancer	0.000119	0.00187	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Docetaxel—ovarian cancer	0.000118	0.00187	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Docetaxel—ovarian cancer	0.000117	0.00186	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000117	0.00184	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Doxorubicin—ovarian cancer	0.000116	0.00184	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—CYTB—ovarian cancer	0.000116	0.00235	CbGpPWpGaD
Adefovir Dipivoxil—Jaundice—Doxorubicin—ovarian cancer	0.000115	0.00182	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Docetaxel—ovarian cancer	0.000115	0.00182	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Epirubicin—ovarian cancer	0.000115	0.00181	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Epirubicin—ovarian cancer	0.000114	0.0018	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Epirubicin—ovarian cancer	0.000113	0.00179	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Doxorubicin—ovarian cancer	0.000113	0.00178	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Epirubicin—ovarian cancer	0.000113	0.00178	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Paclitaxel—ovarian cancer	0.000113	0.00178	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Paclitaxel—ovarian cancer	0.000113	0.00178	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Epirubicin—ovarian cancer	0.000113	0.00178	CcSEcCtD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—TP53—ovarian cancer	0.000112	0.00227	CbGpPWpGaD
Adefovir Dipivoxil—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000112	0.00177	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Doxorubicin—ovarian cancer	0.000111	0.00175	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00011	0.00174	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Docetaxel—ovarian cancer	0.000106	0.00168	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Doxorubicin—ovarian cancer	0.000106	0.00168	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Doxorubicin—ovarian cancer	0.000105	0.00167	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Docetaxel—ovarian cancer	0.000105	0.00166	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000105	0.00166	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000104	0.00165	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000104	0.00165	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Doxorubicin—ovarian cancer	0.000104	0.00165	CcSEcCtD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—SLC5A5—ovarian cancer	0.000103	0.00209	CbGpPWpGaD
Adefovir Dipivoxil—Asthenia—Paclitaxel—ovarian cancer	0.000102	0.00162	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—PPP1CC—ovarian cancer	0.000101	0.00205	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—BRIP1—ovarian cancer	0.000101	0.00205	CbGpPWpGaD
Adefovir Dipivoxil—Pruritus—Paclitaxel—ovarian cancer	0.000101	0.0016	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Epirubicin—ovarian cancer	9.99e-05	0.00158	CcSEcCtD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—SLC2A1—ovarian cancer	9.97e-05	0.00202	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal pain—Docetaxel—ovarian cancer	9.89e-05	0.00156	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Epirubicin—ovarian cancer	9.85e-05	0.00156	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—YAP1—ovarian cancer	9.82e-05	0.00199	CbGpPWpGaD
Adefovir Dipivoxil—Diarrhoea—Paclitaxel—ovarian cancer	9.76e-05	0.00154	CcSEcCtD
Adefovir Dipivoxil—Back pain—Epirubicin—ovarian cancer	9.67e-05	0.00153	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Disease—HSD17B6—ovarian cancer	9.63e-05	0.00195	CbGpPWpGaD
Adefovir Dipivoxil—Body temperature increased—Docetaxel—ovarian cancer	9.56e-05	0.00151	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Docetaxel—ovarian cancer	9.56e-05	0.00151	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	9.49e-05	0.00192	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—AQP3—ovarian cancer	9.43e-05	0.00191	CbGpPWpGaD
Adefovir Dipivoxil—Malnutrition—Doxorubicin—ovarian cancer	9.25e-05	0.00146	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Epirubicin—ovarian cancer	9.24e-05	0.00146	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Doxorubicin—ovarian cancer	9.11e-05	0.00144	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Carbohydrate metabolism—SLC2A1—ovarian cancer	9.09e-05	0.00184	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Paclitaxel—ovarian cancer	9.07e-05	0.00143	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—ATP7B—ovarian cancer	9.04e-05	0.00183	CbGpPWpGaD
Adefovir Dipivoxil—Rash—Paclitaxel—ovarian cancer	9e-05	0.00142	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Paclitaxel—ovarian cancer	8.99e-05	0.00142	CcSEcCtD
Adefovir Dipivoxil—Back pain—Doxorubicin—ovarian cancer	8.94e-05	0.00141	CcSEcCtD
Adefovir Dipivoxil—Headache—Paclitaxel—ovarian cancer	8.94e-05	0.00141	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—CYTB—ovarian cancer	8.8e-05	0.00178	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	8.79e-05	0.00178	CbGpPWpGaD
Adefovir Dipivoxil—Cough—Epirubicin—ovarian cancer	8.72e-05	0.00138	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Docetaxel—ovarian cancer	8.68e-05	0.00137	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	8.62e-05	0.00174	CbGpPWpGaD
Adefovir Dipivoxil—Pruritus—Docetaxel—ovarian cancer	8.56e-05	0.00135	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Doxorubicin—ovarian cancer	8.55e-05	0.00135	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Epirubicin—ovarian cancer	8.51e-05	0.00134	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Epirubicin—ovarian cancer	8.51e-05	0.00134	CcSEcCtD
Adefovir Dipivoxil—Nausea—Paclitaxel—ovarian cancer	8.47e-05	0.00134	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	8.45e-05	0.00134	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Fluoropyrimidine Activity—TP53—ovarian cancer	8.43e-05	0.00171	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—SPARC—ovarian cancer	8.42e-05	0.0017	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	8.39e-05	0.0017	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	8.31e-05	0.00168	CbGpPWpGaD
Adefovir Dipivoxil—Diarrhoea—Docetaxel—ovarian cancer	8.27e-05	0.00131	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Hemostasis—RAD51C—ovarian cancer	8.12e-05	0.00164	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	8.1e-05	0.00164	CbGpPWpGaD
Adefovir Dipivoxil—Cough—Doxorubicin—ovarian cancer	8.07e-05	0.00128	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—FASN—ovarian cancer	8.01e-05	0.00162	CbGpPWpGaD
Adefovir Dipivoxil—Nervous system disorder—Epirubicin—ovarian cancer	8e-05	0.00126	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Epirubicin—ovarian cancer	7.99e-05	0.00126	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Epirubicin—ovarian cancer	7.92e-05	0.00125	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—SLC5A5—ovarian cancer	7.88e-05	0.00159	CbGpPWpGaD
Adefovir Dipivoxil—Chest pain—Doxorubicin—ovarian cancer	7.87e-05	0.00124	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Doxorubicin—ovarian cancer	7.87e-05	0.00124	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	7.82e-05	0.00124	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Epirubicin—ovarian cancer	7.77e-05	0.00123	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Carbohydrate metabolism—PPP2R1A—ovarian cancer	7.73e-05	0.00156	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CHMP4C—ovarian cancer	7.7e-05	0.00156	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PPP1CC—ovarian cancer	7.69e-05	0.00156	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—BRIP1—ovarian cancer	7.69e-05	0.00156	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Docetaxel—ovarian cancer	7.69e-05	0.00122	CcSEcCtD
Adefovir Dipivoxil—Rash—Docetaxel—ovarian cancer	7.62e-05	0.0012	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Docetaxel—ovarian cancer	7.62e-05	0.0012	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—SLC2A1—ovarian cancer	7.61e-05	0.00154	CbGpPWpGaD
Adefovir Dipivoxil—Headache—Docetaxel—ovarian cancer	7.58e-05	0.0012	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—AQP3—ovarian cancer	7.57e-05	0.00153	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	7.53e-05	0.00152	CbGpPWpGaD
Adefovir Dipivoxil—Musculoskeletal discomfort—Epirubicin—ovarian cancer	7.43e-05	0.00117	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Doxorubicin—ovarian cancer	7.4e-05	0.00117	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Doxorubicin—ovarian cancer	7.39e-05	0.00117	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Metabolism—NME2—ovarian cancer	7.37e-05	0.00149	CbGpPWpGaD
Adefovir Dipivoxil—Skin disorder—Doxorubicin—ovarian cancer	7.33e-05	0.00116	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	7.31e-05	0.00148	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—CYP1B1—ovarian cancer	7.29e-05	0.00148	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	7.27e-05	0.00147	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—ATP7B—ovarian cancer	7.25e-05	0.00147	CbGpPWpGaD
Adefovir Dipivoxil—Anorexia—Doxorubicin—ovarian cancer	7.19e-05	0.00114	CcSEcCtD
Adefovir Dipivoxil—Nausea—Docetaxel—ovarian cancer	7.18e-05	0.00114	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Epirubicin—ovarian cancer	7.18e-05	0.00113	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—TUBB3—ovarian cancer	7.15e-05	0.00145	CbGpPWpGaD
Adefovir Dipivoxil—Decreased appetite—Epirubicin—ovarian cancer	7.09e-05	0.00112	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Epirubicin—ovarian cancer	7.04e-05	0.00111	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	6.92e-05	0.0014	CbGpPWpGaD
Adefovir Dipivoxil—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	6.88e-05	0.00109	CcSEcCtD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—AQP3—ovarian cancer	6.82e-05	0.00138	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—YAP1—ovarian cancer	6.81e-05	0.00138	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	6.79e-05	0.00137	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	6.73e-05	0.00136	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—BCL9—ovarian cancer	6.67e-05	0.00135	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal pain—Epirubicin—ovarian cancer	6.67e-05	0.00105	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Doxorubicin—ovarian cancer	6.64e-05	0.00105	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	6.58e-05	0.00133	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	6.58e-05	0.00133	CbGpPWpGaD
Adefovir Dipivoxil—Decreased appetite—Doxorubicin—ovarian cancer	6.56e-05	0.00104	CcSEcCtD
Adefovir Dipivoxil—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	6.55e-05	0.00133	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—AQP3—ovarian cancer	6.54e-05	0.00132	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—ATP7B—ovarian cancer	6.54e-05	0.00132	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal disorder—Doxorubicin—ovarian cancer	6.52e-05	0.00103	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—PPP2R1A—ovarian cancer	6.47e-05	0.00131	CbGpPWpGaD
Adefovir Dipivoxil—Abdominal pain—Epirubicin—ovarian cancer	6.45e-05	0.00102	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Epirubicin—ovarian cancer	6.45e-05	0.00102	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—ATP7B—ovarian cancer	6.27e-05	0.00127	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	6.22e-05	0.00126	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal pain—Doxorubicin—ovarian cancer	6.17e-05	0.000975	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—SOD1—ovarian cancer	6.11e-05	0.00124	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—ABCB1—ovarian cancer	6.01e-05	0.00122	CbGpPWpGaD
Adefovir Dipivoxil—Body temperature increased—Doxorubicin—ovarian cancer	5.97e-05	0.000943	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Doxorubicin—ovarian cancer	5.97e-05	0.000943	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Metabolism—NME2—ovarian cancer	5.92e-05	0.0012	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—TYMS—ovarian cancer	5.9e-05	0.00119	CbGpPWpGaD
Adefovir Dipivoxil—Asthenia—Epirubicin—ovarian cancer	5.85e-05	0.000925	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Epirubicin—ovarian cancer	5.77e-05	0.000912	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—TUBB3—ovarian cancer	5.73e-05	0.00116	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	5.71e-05	0.00116	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—AQP3—ovarian cancer	5.69e-05	0.00115	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	5.66e-05	0.00115	CbGpPWpGaD
Adefovir Dipivoxil—Diarrhoea—Epirubicin—ovarian cancer	5.58e-05	0.000882	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—FASN—ovarian cancer	5.55e-05	0.00112	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	5.53e-05	0.00112	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—VEGFA—ovarian cancer	5.49e-05	0.00111	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	5.47e-05	0.00111	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—SLC5A5—ovarian cancer	5.46e-05	0.0011	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—ATP7B—ovarian cancer	5.46e-05	0.0011	CbGpPWpGaD
Adefovir Dipivoxil—Asthenia—Doxorubicin—ovarian cancer	5.41e-05	0.000856	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Doxorubicin—ovarian cancer	5.34e-05	0.000844	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—SLC2A1—ovarian cancer	5.27e-05	0.00107	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—ovarian cancer	5.23e-05	0.00106	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Epirubicin—ovarian cancer	5.19e-05	0.00082	CcSEcCtD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—TUBB3—ovarian cancer	5.17e-05	0.00105	CbGpPWpGaD
Adefovir Dipivoxil—Diarrhoea—Doxorubicin—ovarian cancer	5.16e-05	0.000816	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—YAP1—ovarian cancer	5.16e-05	0.00104	CbGpPWpGaD
Adefovir Dipivoxil—Rash—Epirubicin—ovarian cancer	5.14e-05	0.000813	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Epirubicin—ovarian cancer	5.14e-05	0.000812	CcSEcCtD
Adefovir Dipivoxil—Headache—Epirubicin—ovarian cancer	5.11e-05	0.000808	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—CYP1B1—ovarian cancer	5.05e-05	0.00102	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PPP1CC—ovarian cancer	4.96e-05	0.001	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—TUBB3—ovarian cancer	4.96e-05	0.001	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Epirubicin—ovarian cancer	4.84e-05	0.000766	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Doxorubicin—ovarian cancer	4.8e-05	0.000758	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	4.77e-05	0.000965	CbGpPWpGaD
Adefovir Dipivoxil—Rash—Doxorubicin—ovarian cancer	4.76e-05	0.000752	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Doxorubicin—ovarian cancer	4.75e-05	0.000751	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—CAV1—ovarian cancer	4.75e-05	0.000962	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYTB—ovarian cancer	4.75e-05	0.000962	CbGpPWpGaD
Adefovir Dipivoxil—Headache—Doxorubicin—ovarian cancer	4.73e-05	0.000747	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	4.67e-05	0.000944	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	4.61e-05	0.000932	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PPP2R1A—ovarian cancer	4.48e-05	0.000907	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Doxorubicin—ovarian cancer	4.48e-05	0.000708	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Hemostasis—SPARC—ovarian cancer	4.34e-05	0.000878	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PIK3CG—ovarian cancer	4.33e-05	0.000876	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—TUBB3—ovarian cancer	4.31e-05	0.000873	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—FASN—ovarian cancer	4.21e-05	0.000851	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—ABCB1—ovarian cancer	4.16e-05	0.000842	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PPP1CC—ovarian cancer	4.15e-05	0.000841	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—BRIP1—ovarian cancer	4.15e-05	0.000841	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—SLC5A5—ovarian cancer	4.14e-05	0.000837	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—TYMS—ovarian cancer	4.09e-05	0.000827	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—ovarian cancer	4.07e-05	0.000824	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Ectoderm Differentiation—CTNNB1—ovarian cancer	4.03e-05	0.000816	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—SLC2A1—ovarian cancer	4e-05	0.000809	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CYP1B1—ovarian cancer	3.83e-05	0.000775	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.83e-05	0.000774	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYTB—ovarian cancer	3.81e-05	0.000771	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PIK3CD—ovarian cancer	3.81e-05	0.00077	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HDAC6—ovarian cancer	3.76e-05	0.000761	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.69e-05	0.000748	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.64e-05	0.000736	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	3.58e-05	0.000725	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.45e-05	0.000698	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PPP2R1A—ovarian cancer	3.4e-05	0.000688	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—BRIP1—ovarian cancer	3.33e-05	0.000674	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PPP1CC—ovarian cancer	3.33e-05	0.000674	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.33e-05	0.000674	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PIK3CB—ovarian cancer	3.32e-05	0.000671	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.31e-05	0.000669	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—CAV1—ovarian cancer	3.29e-05	0.000667	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Ectoderm Differentiation—MYC—ovarian cancer	3.27e-05	0.000661	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—XIAP—ovarian cancer	3.26e-05	0.00066	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.19e-05	0.000646	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—SMARCA4—ovarian cancer	3.18e-05	0.000643	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—ABCB1—ovarian cancer	3.15e-05	0.000638	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—SOD1—ovarian cancer	3.15e-05	0.000638	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PPP2R1A—ovarian cancer	3.14e-05	0.000635	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	3.12e-05	0.000632	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—EREG—ovarian cancer	3.1e-05	0.000627	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—TYMS—ovarian cancer	3.1e-05	0.000627	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PIK3CG—ovarian cancer	3e-05	0.000607	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.92e-05	0.00059	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.88e-05	0.000582	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PTEN—ovarian cancer	2.87e-05	0.00058	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—IL2—ovarian cancer	2.87e-05	0.00058	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—YAP1—ovarian cancer	2.79e-05	0.000564	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.78e-05	0.000563	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—FASN—ovarian cancer	2.71e-05	0.000549	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PARP1—ovarian cancer	2.7e-05	0.000547	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PIK3CD—ovarian cancer	2.64e-05	0.000534	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.63e-05	0.000532	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—SLC2A1—ovarian cancer	2.58e-05	0.000521	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.52e-05	0.00051	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CAV1—ovarian cancer	2.5e-05	0.000505	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	2.44e-05	0.000493	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—CAV1—ovarian cancer	2.3e-05	0.000466	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	2.3e-05	0.000466	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PIK3CB—ovarian cancer	2.3e-05	0.000465	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PIK3CG—ovarian cancer	2.27e-05	0.00046	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—FASN—ovarian cancer	2.27e-05	0.00046	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—YAP1—ovarian cancer	2.23e-05	0.000452	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—SLC5A5—ovarian cancer	2.23e-05	0.000452	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.19e-05	0.000444	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	2.19e-05	0.000444	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PPP2R1A—ovarian cancer	2.19e-05	0.000443	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—SLC2A1—ovarian cancer	2.16e-05	0.000437	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PIK3CG—ovarian cancer	2.1e-05	0.000425	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP1B1—ovarian cancer	2.07e-05	0.000419	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PIK3CA—ovarian cancer	2.02e-05	0.000409	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PIK3CD—ovarian cancer	2e-05	0.000405	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PTEN—ovarian cancer	1.99e-05	0.000402	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	1.9e-05	0.000385	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PIK3CD—ovarian cancer	1.85e-05	0.000373	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PPP2R1A—ovarian cancer	1.83e-05	0.000371	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—FASN—ovarian cancer	1.82e-05	0.000369	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—SLC5A5—ovarian cancer	1.79e-05	0.000363	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PIK3CB—ovarian cancer	1.74e-05	0.000353	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TERT—ovarian cancer	1.74e-05	0.000352	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—SLC2A1—ovarian cancer	1.73e-05	0.00035	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ABCB1—ovarian cancer	1.7e-05	0.000345	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—TYMS—ovarian cancer	1.67e-05	0.000339	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP1B1—ovarian cancer	1.66e-05	0.000336	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—AKT1—ovarian cancer	1.65e-05	0.000334	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CAV1—ovarian cancer	1.61e-05	0.000326	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PIK3CB—ovarian cancer	1.61e-05	0.000326	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	1.55e-05	0.000315	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—IL6ST—ovarian cancer	1.53e-05	0.000309	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PTEN—ovarian cancer	1.51e-05	0.000305	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—IL2—ovarian cancer	1.48e-05	0.000299	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PPP2R1A—ovarian cancer	1.47e-05	0.000298	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—APC—ovarian cancer	1.47e-05	0.000297	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PIK3CA—ovarian cancer	1.4e-05	0.000284	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ABCB1—ovarian cancer	1.37e-05	0.000277	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CAV1—ovarian cancer	1.35e-05	0.000273	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—TYMS—ovarian cancer	1.34e-05	0.000272	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PIK3CD—ovarian cancer	1.29e-05	0.000261	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—VEGFA—ovarian cancer	1.26e-05	0.000254	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—NRAS—ovarian cancer	1.24e-05	0.000251	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PIK3CG—ovarian cancer	1.23e-05	0.000249	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—MAPK3—ovarian cancer	1.19e-05	0.00024	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—AKT1—ovarian cancer	1.14e-05	0.000232	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—ERBB2—ovarian cancer	1.14e-05	0.00023	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—MAPK1—ovarian cancer	1.13e-05	0.000229	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PIK3CB—ovarian cancer	1.12e-05	0.000227	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MTOR—ovarian cancer	1.12e-05	0.000227	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CAV1—ovarian cancer	1.08e-05	0.000219	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PIK3CD—ovarian cancer	1.08e-05	0.000218	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—KRAS—ovarian cancer	1.07e-05	0.000216	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PIK3CA—ovarian cancer	1.06e-05	0.000215	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CDKN1B—ovarian cancer	1.05e-05	0.000213	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CTNNB1—ovarian cancer	9.96e-06	0.000202	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PIK3CG—ovarian cancer	9.85e-06	0.000199	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PIK3CA—ovarian cancer	9.81e-06	0.000198	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PTEN—ovarian cancer	9.71e-06	0.000196	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—TP53—ovarian cancer	9.49e-06	0.000192	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PIK3CB—ovarian cancer	9.41e-06	0.00019	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—HRAS—ovarian cancer	9.07e-06	0.000184	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—STAT3—ovarian cancer	8.68e-06	0.000176	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—AKT1—ovarian cancer	8.68e-06	0.000176	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—NRAS—ovarian cancer	8.66e-06	0.000175	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PIK3CD—ovarian cancer	8.66e-06	0.000175	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MAPK3—ovarian cancer	8.3e-06	0.000168	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PTEN—ovarian cancer	8.13e-06	0.000165	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MYC—ovarian cancer	8.07e-06	0.000163	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—AKT1—ovarian cancer	8.01e-06	0.000162	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MAPK1—ovarian cancer	7.89e-06	0.00016	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—EGFR—ovarian cancer	7.89e-06	0.00016	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PIK3CB—ovarian cancer	7.55e-06	0.000153	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—KRAS—ovarian cancer	7.45e-06	0.000151	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PIK3CA—ovarian cancer	6.85e-06	0.000139	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PTEN—ovarian cancer	6.52e-06	0.000132	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HRAS—ovarian cancer	6.34e-06	0.000128	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—IL6—ovarian cancer	6.06e-06	0.000123	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PIK3CA—ovarian cancer	5.74e-06	0.000116	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—AKT1—ovarian cancer	5.59e-06	0.000113	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—AKT1—ovarian cancer	4.69e-06	9.48e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PIK3CA—ovarian cancer	4.6e-06	9.31e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—AKT1—ovarian cancer	3.76e-06	7.61e-05	CbGpPWpGaD
